Why Is The Drug Discovery Market So Slow?
Mika Newton and Tom Neyarapally discuss how advancements in data, AI tools, and computing power are transforming drug discovery, particularly in oncology. They explore patient-centric approaches, in silico screening, and strategies to reduce the time and cost of bringing new treatments to market.